Outcome of lateral tarsal strip in managing the paralytic eyelid eversion
Main Article Content
Abstract
Background: Paralytic eyelid eversion (ectropion) is prevalent in admitted individuals with ineffectiveness of the
cranial nerve 7, brain tumor, and leprosy. Neurogenic ectropion is an unusual eyelid problem due to impairment of
the 7th cranial nerve, which can cause multiple difficulties due to inadequate corneal protection.
Objective: To describe the surgical efficacy of the lateral tarsal strip (LTS) technique in managing the paralytic
eyelid eversion or ectropion.
Methods: This study was conducted prospectively at a third-level eye care center in Bangladesh for 3 years
commencing from 2019, involving 26 patients. The included patients involved the paralytic eversion of the inferior
lid who underwent LTS surgery. The principal findings, like surgical outcome, contouring of the lid, complications,
follow-up time, and recurrence, were recorded. All the study subjects were examined within 14 days, and the
standard follow-up period was 12 months.
Results: The full number of studied cases was 26. In this research, males represented 73%, while females
accounted for 27%. The average age was 57.8 14.9 years and ranged from 24 to 72. In operated cases, the
right eyes were 15 cases (57.70%), and the left eyes were 11 cases (42.30%). The final better outcome of surgical
modification was 93%. Twenty-four eyelids had an outstandin appearance after surgery. Mild complication includes
postoperative lid swelling in seven eyelids, which was resolved within 7 days. Just two patients had mild lid eversion
at the end of the follow-up schedule.
Conclusion: LTS is a simple, easy-to-maintain, and potent technique to correct paralytic eyelid eversion. It
is essential to fixate the LTS above the lateral canthus to minimize new occurrence, and achieve the desired
clinical outcome.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
This has been implemented from Jan 2024 onwards